Skip to main content
Radiolab

Staph Retreat

31 min episode · 2 min read
·
Mary Mckenna

Episode

31 min

Read time

2 min

Topics

Health & Wellness, Fundraising & VC, Psychology & Behavior

AI-Generated Summary

Key Takeaways

  • Antibiotic Resistance Timeline: Every major antibiotic has faced resistance within months to years of release — methicillin lasted just eleven months before resistance emerged in 1961. After 2000, pharmaceutical companies largely abandoned antibiotic development because a ten-year, billion-dollar development cycle cannot recoup costs before resistance renders the drug obsolete.
  • Resistance Decay Principle: When an antibiotic is removed from circulation, bacterial resistance to it can decline over time. A compound that stopped working a thousand years ago may regain effectiveness today precisely because it was abandoned. This suggests rotating historical remedies in and out of use could extend their viable lifespan against evolving pathogens.
  • Bald's Eyesalve Formula: The Anglo-Saxon recipe combines equal parts onion and another allium (leek or garlic), bovine bile, and wine, mixed in a brass or bronze vessel and stored for nine days before use. Each ingredient contributes antimicrobial properties, and the copper vessel adds an additional antibacterial element absent from modern preparation methods.
  • MRSA Kill Rate: When tested against methicillin-resistant Staphylococcus aureus in laboratory wound models, Bald's Eyesalve eliminated approximately 90% of bacterial cells. The result was replicated across five separate trials and independently confirmed by a collaborator at Texas Tech University, ruling out contamination or experimental error as explanations.
  • Phase One Safety Milestone: As of 2022, Bald's Eyesalve cleared phase one clinical safety trials in healthy human subjects. Researchers have since identified the specific active chemical compounds responsible for antibacterial activity, enabling a distilled, standardized formulation — a necessary step before the remedy can advance toward pharmaceutical approval and clinical use.

What It Covers

Radiolab traces the antibiotic resistance crisis from Alexander Fleming's 1928 penicillin discovery through today's MRSA superbugs, then follows microbiologist Freya Harrison and historian Christina Lee as they test a 1,100-year-old Anglo-Saxon eye remedy from Bald's Leechbook against drug-resistant staph bacteria.

Key Questions Answered

  • Antibiotic Resistance Timeline: Every major antibiotic has faced resistance within months to years of release — methicillin lasted just eleven months before resistance emerged in 1961. After 2000, pharmaceutical companies largely abandoned antibiotic development because a ten-year, billion-dollar development cycle cannot recoup costs before resistance renders the drug obsolete.
  • Resistance Decay Principle: When an antibiotic is removed from circulation, bacterial resistance to it can decline over time. A compound that stopped working a thousand years ago may regain effectiveness today precisely because it was abandoned. This suggests rotating historical remedies in and out of use could extend their viable lifespan against evolving pathogens.
  • Bald's Eyesalve Formula: The Anglo-Saxon recipe combines equal parts onion and another allium (leek or garlic), bovine bile, and wine, mixed in a brass or bronze vessel and stored for nine days before use. Each ingredient contributes antimicrobial properties, and the copper vessel adds an additional antibacterial element absent from modern preparation methods.
  • MRSA Kill Rate: When tested against methicillin-resistant Staphylococcus aureus in laboratory wound models, Bald's Eyesalve eliminated approximately 90% of bacterial cells. The result was replicated across five separate trials and independently confirmed by a collaborator at Texas Tech University, ruling out contamination or experimental error as explanations.
  • Phase One Safety Milestone: As of 2022, Bald's Eyesalve cleared phase one clinical safety trials in healthy human subjects. Researchers have since identified the specific active chemical compounds responsible for antibacterial activity, enabling a distilled, standardized formulation — a necessary step before the remedy can advance toward pharmaceutical approval and clinical use.

Notable Moment

When Texas Tech collaborator Kendra Rumbaugh received her first results showing Bald's Eyesalve destroying MRSA cultures, her entire response to Harrison and Lee was a three-word expletive. That reaction from a credentialed researcher encapsulates how thoroughly the outcome defied professional expectations.

Know someone who'd find this useful?

You just read a 3-minute summary of a 28-minute episode.

Get Radiolab summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from Radiolab

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Science Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Radiolab.

Every Monday, we deliver AI summaries of the latest episodes from Radiolab and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime